NWAM LLC’s Elevance Health ELV Stock Holding History

NWAM LLC’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-428	Closed	-$223K	–	611
2024 Q3	$223K	Sell	428 -3	-0.7%	-$1.6K	0.01%	569
2024 Q2	$234K	Sell	431 -15	-3%	-$7.93K	0.07%	133
2024 Q1	$238K	Sell	446 -4	-0.9%	-$1.99K	0.02%	493
2023 Q4	$212K	Sell	450 -10	-2%	-$4.62K	0.02%	516
2023 Q3	$201K	Sell	460 -56	-11%	-$25.4K	0.02%	482
2023 Q2	$230K	Buy	516 +24	+5%	+$11.1K	0.02%	476
2023 Q1	$227K	Sell	492 -81	-14%	-$38.5K	0.02%	426
2022 Q4	$294K	Buy	573 +16	+3%	+$8.12K	0.03%	413
2022 Q3	$253K	Buy	557 +45	+9%	+$21.5K	0.02%	418
2022 Q2	$245K	Sell	512 -203	-28%	-$100K	0.02%	447
2022 Q1	$351K	Buy	+715	New	+$327K	0.03%	391
2021 Q4	–	Sell	-560	Closed	-$209K	–	512
2021 Q3	$209K	Buy	+560	New	+$213K	0.02%	465
2020 Q1	–	Sell	-1,421	Closed	-$429K	–	380
2019 Q4	$429K	Buy	+1,421	New	+$391K	0.07%	243

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

NWAM LLC's ELV Position: Q4 2024 in Review

NWAM LLC sold out of Elevance Health (ELV) in Q4 2024, closing a stake of 428 shares — an estimated $223K sold.

NWAM LLC first reported a position in ELV in Q4 2019 and held it in 13 quarters. The position peaked at $429K in Q4 2019. 1,602 funds tracked by Wall St. Rank hold ELV as of Q4 2024.

NWAM LLC reported no remaining Elevance Health position as of Q4 2024 after selling out during the quarter.
NWAM LLC sold 428 Elevance Health shares in Q4 2024, an estimated $223K.
NWAM LLC first reported a position in Elevance Health in Q4 2019 and held it in 13 quarters.
NWAM LLC's Elevance Health position peaked at $429K in Q4 2019.
1,602 funds tracked by Wall St. Rank held Elevance Health as of Q4 2024.

Based on NWAM LLC's 13F filing for Q4 2024, filed 5 Feb 2025.